Literature DB >> 10189351

Signaling in myocardial hypertrophy: life after calcineurin?

P H Sugden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10189351     DOI： 10.1161/01.res.84.6.633

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  35 in total

Review 1.  Postinfarction left ventricular remodelling: where are the theories and trials leading us?

Authors:  Z R Yousef; S R Redwood; M S Marber
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

2.  Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.

Authors:  N H Purcell; G Tang; C Yu; F Mercurio; J A DiDonato; A Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

3.  Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Authors:  T Taigen; L J De Windt; H W Lim; J D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  Modeling hypertrophic IP3 transients in the cardiac myocyte.

Authors:  Michael Cooling; Peter Hunter; Edmund J Crampin
Journal:  Biophys J       Date:  2007-08-10       Impact factor: 4.033

Review 5.  Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Andrea P Babick; Shelley Zieroth; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

6.  Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1.

Authors:  A Clerk; F H Pham; S J Fuller; E Sahai; K Aktories; R Marais; C Marshall; P H Sugden
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

7.  Calcitonin gene-related peptide is not essential for the development of pressure overload-induced hypertrophy in vivo.

Authors:  M E Young; K A Okerberg; C R Wilson; D A Deferrari; J Ying; P Guthrie; P Razeghi; F J Clubb; H Taegtmeyer
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

8.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

9.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

10.  Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.

Authors:  H Diedrichs; C Mei; K F Frank; B Boelck; R H G Schwinger
Journal:  J Mol Med (Berl)       Date:  2004-08-20       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.